Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tegoprazan 是一种口服有效的、高选择性胃 H+/K+-ATP 酶 (H+/K+-ATPase) 抑制剂,能够控制胃酸分泌和运动,在体外检测的对猪、犬、人的 H+/K+-ATP 酶的 IC50为0.29-0.52 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 728 | 现货 | ||
5 mg | ¥ 1,620 | 现货 | ||
10 mg | ¥ 2,570 | 现货 | ||
25 mg | ¥ 5,160 | 现货 | ||
50 mg | ¥ 7,930 | 现货 | ||
100 mg | ¥ 10,600 | 现货 | ||
200 mg | ¥ 14,300 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,780 | 现货 |
产品描述 | Tegoprazan is a potassium-competitive acid blocker and is a potent, oral active, and highly selective inhibitor of gastric H+/K+-ATPase. That could control gastric acid secretion and motility (IC50: ranging from 0.29-0.52 μM for porcine, canine, and human H+/K+-ATPases in vitro). |
靶点活性 | H+, K+-ATPase:0.29-0.52 μM |
体外活性 | Tegoprazan inhibits gastric H+/K+-ATPase in a potassium-competitive and reversible manner and it also inhibits porcine, canine, and human H+/K+-ATPase activity. Tegoprazan (3 μM) inhibits 86% of H+/K+-ATPase activity, whereas the inhibition is decreased to 34% after the dilution of Tegoprazan concentration to 0.15 μM [1]. |
体内活性 | Tegoprazan (1.0-3.0 mg/kg, p.o.) reverses the pentagastrin-induced acidified gastric pH to the neutral range. Tegoprazan (1.0 mg/kg, p.o.) effectively and fully inhibits histamine-induced gastric acid secretion in dogs. Tegoprazan (3 mg/kg, p.o.) immediately evokes a gastric phase III contraction of the migrating motor complex in pentagastrin-treated dogs [1]. |
分子量 | 387.38 |
分子式 | C20H19F2N3O3 |
CAS No. | 942195-55-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (58.08 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5814 mL | 12.9072 mL | 25.8144 mL | 64.5361 mL |
5 mM | 0.5163 mL | 2.5814 mL | 5.1629 mL | 12.9072 mL | |
10 mM | 0.2581 mL | 1.2907 mL | 2.5814 mL | 6.4536 mL | |
20 mM | 0.1291 mL | 0.6454 mL | 1.2907 mL | 3.2268 mL | |
50 mM | 0.0516 mL | 0.2581 mL | 0.5163 mL | 1.2907 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Tegoprazan 942195-55-3 Membrane transporter/Ion channel ATPase Proton pump pentagastrin Proton Pump acid gastric secretion inhibit Inhibitor inhibitor